Literature DB >> 10442311

Quality of life 5-10 years after primary surgery for oral and oro-pharyngeal cancer.

S N Rogers1, L Hannah, D Lowe, P Magennis.   

Abstract

This study reports the quality of life in long-term survivors of oral cancer treated by primary surgery. Two hundred and twenty patients were treated at the Regional Maxillofacial Unit between the years 1987 and 1992, of which 48 were alive and disease free in July 1997. Thirty-eight patients self-completed the following questionnaires: University of Washington Quality of Life Scale (UW-QOL), the European Organisation for Research and Treatment of Cancer (EORTC) core QOQ-C30 (v2) and the EORTC Head and Neck (H&N35). Results for this group were compared with the one year findings of a similar prospective cohort treated in 1995. Long-term survivors tended to report a good or excellent quality of life. Quality of life deficits in the long-term survivors were similar to those at one year. However, a larger longitudinal study is required to test this relationship more rigorously. The similarity of domain scores suggests that quality of life evaluation at one year is a useful marker of long-term outcome.

Entities:  

Mesh:

Year:  1999        PMID: 10442311     DOI: 10.1016/s1010-5182(99)80049-3

Source DB:  PubMed          Journal:  J Craniomaxillofac Surg        ISSN: 1010-5182            Impact factor:   2.078


  22 in total

1.  Oral cancer.

Authors:  C Scully; S Porter
Journal:  West J Med       Date:  2001-05

2.  Human papillomavirus-positive oral cavity and oropharyngeal cancer patients do not have better quality-of-life trajectories.

Authors:  Arun Sharma; Eduardo Méndez; Bevan Yueh; Pawadee Lohavanichbutr; John Houck; David R Doody; Neal D Futran; Melissa P Upton; Stephen M Schwartz; Chu Chen
Journal:  Otolaryngol Head Neck Surg       Date:  2012-01-24       Impact factor: 3.497

3.  Assessment of the quality of life of the patients with treated oral cancer in Iran.

Authors:  Bahareh Tahani; Sayed Mohammad Razavi; Hamid Emami; Fatemeh Alamchi
Journal:  Oral Maxillofac Surg       Date:  2017-09-25

4.  Restorative aspects of oral cancer reconstruction.

Authors:  C W Barclay; E C Foster; C L Taylor
Journal:  Br Dent J       Date:  2018-11-09       Impact factor: 1.626

5.  [Quality of life in patients with oropharyngeal carcinoma. Gender influences the subjective evaluation].

Authors:  I Baumann; M Seibolt; I M Zalaman; K Dietz; P K Plinkert; M M Maassen
Journal:  HNO       Date:  2006-05       Impact factor: 1.284

6.  'What will I be like' after my diagnosis of head and neck cancer?

Authors:  S N Rogers; E S Hogg; W K A Cheung; L K L Lai; P Jassal; D Lowe; A Kanatas
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-07-22       Impact factor: 2.503

7.  Sociodemographic risk indicators for depressive symptoms among persons with oral cancer or oral epithelial dysplasia.

Authors:  Susan Reisine; Douglas E Morse; Walter J Psoter; Ellen Eisenberg; Donald Cohen; Deborah Cleveland; Mirseyed Mohit-Tabatabai
Journal:  J Oral Maxillofac Surg       Date:  2005-04       Impact factor: 1.895

8.  Evaluation of Non-vascular Fibula Graft for Mandibular Reconstruction.

Authors:  Sathya Kumar Devireddy; M Senthil Murugan; R V Kishore Kumar; Rajasekhar Gali; Sridhar Reddy Kanubaddy; M Sunayana
Journal:  J Maxillofac Oral Surg       Date:  2014-08-13

9.  Long-term quality of life and its predictive factors after oncologic surgery and microvascular reconstruction in patients with oral or oropharyngeal cancer.

Authors:  Cédric S Pierre; Olivier Dassonville; Emmanuel Chamorey; Gilles Poissonnet; Marc Ettaiche; José Santini; Frédéric Peyrade; Karen Benezery; Anne Sudaka; Alexandre Bozec
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-06-16       Impact factor: 2.503

10.  Quality of life in head and neck cancer patients after tumor therapy and subsequent rehabilitation: an exploratory study.

Authors:  Judit Nagy; Gábor Braunitzer; Márk Antal; Csaba Berkovits; Péter Novák; Katalin Nagy
Journal:  Qual Life Res       Date:  2013-06-04       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.